ANERGIS
Anergis, a clinical-stage biopharmaceutical company, discovers and develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization. It offers vaccines against birch pollen, ragweed pollen, and house dust mite allergies. Francois Spertini founded Anergis in 2001. Its headquarters in Lausanne in Switzerland.
ANERGIS
Social Links:
Industry:
Biotechnology Health Care Life Science Medical Personal Health
Founded:
2001-01-01
Address:
Epalinges, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.anergis.ch
Total Employee:
11+
Status:
Active
Contact:
0041-216519223
Email Addresses:
[email protected]
Total Funding:
49 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Nginx ReCAPTCHA ReCAPTCHA V2 CloudFront Pound Sterling Japanese Yen
Similar Organizations
Current Employees Featured
Founder
Investors List
Renaissance
Renaissance investment in Series C - Anergis
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Series C - Anergis
BioMedPartners
BioMedPartners investment in Series C - Anergis
BioMedPartners
BioMedPartners investment in Series B - Anergis
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Series B - Anergis
Renaissance
Renaissance investment in Series B - Anergis
Renaissance
Renaissance investment in Series A - Anergis
BioMedPartners
BioMedPartners investment in Series A - Anergis
VINCI CAPITAL
VINCI CAPITAL investment in Series A - Anergis
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Series A - Anergis
Official Site Inspections
http://www.anergis.ch
- Host name: 104.247.81.50
- IP address: 104.247.81.50
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
